Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 17/20 | 0.56 |
| ▸ | PIK3CA | P42336 | 16/20 | 0.56 |
| ▸ | PIK3CB | P42338 | 16/20 | 0.56 |
| ▸ | PIK3CG | P48736 | 16/20 | 0.56 |
| ▸ | PRKDC | P78527 | 16/20 | 0.56 |
| ▸ | ABL1 | P00519 | 14/20 | 0.56 |
| ▸ | EGFR | P00533 | 14/20 | 0.56 |
| ▸ | HCK | P08631 | 14/20 | 0.56 |
| ▸ | SRC | P12931 | 14/20 | 0.56 |
| ▸ | MTOR | P42345 | 14/20 | 0.56 |
| ▸ | EPHB4 | P54760 | 14/20 | 0.56 |
| ▸ | PI4KB | Q9UBF8 | 7/20 | 0.56 |
| ▸ | KDR | P35968 | 13/20 | 0.52 |
| ▸ | NUDT14 | O95848 | 1/20 | 0.48 |
| ▸ | NUDT5 | Q9UKK9 | 1/20 | 0.48 |
| ▸ | BTK | Q06187 | 1/20 | 0.46 |
| ▸ | LCK | P06239 | 1/20 | 0.43 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL234181 | 0.72 | SRC (0.80) | PIK3CDPIK3CAPIK3CBPIK3CGPRKDC | |
| SCHEMBL23917270 | 0.72 | PIK3CD (1.00) | PIK3CDPIK3CAPIK3CBPIK3CGPRKDC | |
| SCHEMBL13201532 | 0.72 | PIK3CD (0.70) | PIK3CDPIK3CAPIK3CBPIK3CGPRKDC | |
| SCHEMBL130752 | 0.71 | NUDT14 (0.74) | PIK3CDPIK3CAPIK3CBPIK3CGPRKDC | |
| SCHEMBL130513 | 0.71 | SRC (0.79) | PIK3CDPIK3CAPIK3CBPIK3CGPRKDC | |
| SCHEMBL129615 | 0.71 | SRC (0.79) | PIK3CDPIK3CAPIK3CBPIK3CGPRKDC | |
| SCHEMBL21079131 | 0.70 | NUDT14 (0.66) | PIK3CDPIK3CAPIK3CBPIK3CGPRKDC | |
| SCHEMBL30782445 | 0.70 | NUDT14 (0.69) | PIK3CDPIK3CAPIK3CBPIK3CGPRKDC | |
| SCHEMBL12366 | 0.70 | NUDT14 (0.69) | PIK3CDPIK3CAPIK3CBPIK3CGPRKDC | |
| SCHEMBL218160 | 0.70 | SRC (0.75) | PIK3CDPIK3CAPIK3CBPIK3CGPRKDC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120059001-A1 | NOVEL KINASE MODULATORS | INCOZEN THERAPEUTICS PVT. LTD. (IN) | 2012-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120059001-A1 | NOVEL KINASE MODULATORS | PRKCA, PRKCH, PRKCB | PIK3CD 70/4885PIK3CA 143/4885PIK3CB 33/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.